Provided by Tiger Trade Technology Pte. Ltd.

Park Hotels & Resorts Inc.

11.20
-0.2200-1.93%
Post-market: 11.200.00000.00%18:42 EST
Volume:4.42M
Turnover:49.69M
Market Cap:2.24B
PE:-159.77
High:11.47
Open:11.44
Low:11.16
Close:11.42
52wk High:13.22
52wk Low:8.27
Shares:199.90M
Float Shares:195.63M
Volume Ratio:1.13
T/O Rate:2.26%
Dividend:1.00
Dividend Rate:8.93%
EPS(TTM):-0.0701
EPS(LYR):1.01
ROE:--
ROA:1.89%
PB:0.66
PE(LYR):11.09

Loading ...

Earning Preview: Park Hotels & Resorts Inc. this quarter’s revenue is expected to increase by 2.38%, and institutional views are bearish

Earnings Agent
·
Feb 12

Cantor Fitzgerald Reaffirms Their Hold Rating on Park Hotels & Resorts (PK)

TIPRANKS
·
Yesterday

Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Feb 12

Buy Rating on Tectonic: Differentiated TX45 Strategy, Favorable PK Profile, and Sufficient Cash Runway to Phase 2 Readouts

TIPRANKS
·
Feb 10

Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288

GlobeNewswire
·
Feb 06

Did Park Hotels & Resorts' (PK) Portfolio Shift and Refinancing Just Reframe Its Investment Narrative?

Simply Wall St.
·
Feb 06

2025 Performance Forecasts Reveal Alcohol Producers' Resilience Under Pressure

Deep News
·
Feb 05

Park Hotels & Resorts Is Maintained at Hold by Truist Securities

Dow Jones
·
Feb 03

Truist Trims Price Target on Park Hotels & Resorts to $11 From $12, Keeps Hold Rating

MT Newswires Live
·
Feb 03

J.P. Morgan Sticks to Their Sell Rating for Park Hotels & Resorts (PK)

TIPRANKS
·
Feb 03

U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp

Reuters
·
Feb 03

What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment?

Benzinga_recent_news
·
Feb 03

Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™

GlobeNewswire
·
Feb 02

Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth

GlobeNewswire
·
Feb 02

A Look At Park Hotels & Resorts (PK) Valuation After Mixed Recent Share Price Performance

Simply Wall St.
·
Jan 30

Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza

GlobeNewswire
·
Jan 26

BRIEF-Park Hotels & Resorts Inc. Announces Tax Treatment Of 2025 Dividends

Reuters
·
Jan 21

Park Hotels & Resorts Inc. Announces $1.00 Per Share 2025 Dividend Distribution

Reuters
·
Jan 21

Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson

GlobeNewswire
·
Jan 20

Weekly Scan of 40 New Funds: 26 Asset Managers Including Fullgoal, Penghua, ICBC Credit Suisse, ChinaAMC, and E Fund Compete with Thematic Index, FOF Stability, and Mixed Growth Offerings

Deep News
·
Jan 19